Binds to Macrophage Mannose Receptor on Lymphatic Endothelium and Supports Lymphocyte Migration via Afferent Lymphatics Short Communication
暂无分享,去创建一个
[1] K. Ley,et al. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. , 2011, Blood.
[2] R. Sackstein. The biology of CD44 and HCELL in hematopoiesis: the ‘step 2-bypass pathway’ and other emerging perspectives , 2011, Current opinion in hematology.
[3] S. Jalkanen,et al. Macrophage mannose receptor on lymphatics controls cell trafficking. , 2008, Blood.
[4] M. Mummert,et al. Langerhans cells in CD44-deficient mice emigrate from the epidermis but fail to reach the lymph nodes after hapten application. , 2004, The Journal of investigative dermatology.
[5] P. Heikkilä,et al. Mannose receptor (MR) and common lymphatic endothelial and vascular endothelial receptor (CLEVER)-1 direct the binding of cancer cells to the lymph vessel endothelium. , 2003, Cancer research.
[6] T. Uede,et al. Osteopontin Is Involved in the Initiation of Cutaneous Contact Hypersensitivity by Inducing Langerhans and Dendritic Cell Migration to Lymph Nodes , 2001, Journal of Experimental Medicine.
[7] S. Jalkanen,et al. Mannose Receptor Is a Novel Ligand for L-Selectin and Mediates Lymphocyte Binding to Lymphatic Endothelium , 2001, The Journal of experimental medicine.
[8] M. Nussenzweig,et al. The Cysteine-Rich Domain of the Macrophage Mannose Receptor Is a Multispecific Lectin That Recognizes Chondroitin Sulfates a and B and Sulfated Oligosaccharides of Blood Group Lewisa and Lewisx Types in Addition to the Sulfated N-Glycans of Lutropin , 2000, The Journal of experimental medicine.
[9] F. Hilberg,et al. CD44-deficient mice develop normally with changes in subpopulations and recirculation of lymphocyte subsets. , 1999, Journal of immunology.
[10] K. Bennett,et al. Chondroitin sulphate composition and structure in alternatively spliced CD44 fusion proteins. , 1997, The Biochemical journal.
[11] M. Miyasaka,et al. Characterization of a 180 kDa molecule apparently reactive with recombinant L-selectin , 1997, Glycoconjugate Journal.
[12] S. Jalkanen,et al. Biochemical properties of glycoproteins involved in lymphocyte recognition of high endothelial venules in man. , 1988, Journal of immunology.
[13] J. R. de los Toyos,et al. Lymphocyte recognition of high endothelium: antibodies to distinct epitopes of an 85-95-kD glycoprotein antigen differentially inhibit lymphocyte binding to lymph node, mucosal, or synovial endothelial cells , 1987, The Journal of cell biology.
[14] S Gordon,et al. Macrophage receptors and immune recognition. , 2005, Annual review of immunology.
[15] J. Sleeman,et al. CD44 variants but not CD44s cooperate with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. , 1999, Cancer research.